Flisiak Robert, Zarębska-Michaluk Dorota, Brzdęk Michał, Rorat Marta, Dobrowolska Krystyna, Kozielewicz Dorota, Stankiewicz Magdalena, Moniuszko-Malinowska Anna, Rogalska Magdalena, Supronowicz Łukasz, Piotrowski Damian, Sikorska Katarzyna, Mazur Włodzimierz, Kowalska Justyna, Rzymski Piotr
Department of Infectious Diseases and Hepatology, Medical University of Białystok, 15-540 Białystok, Poland.
Department of Infectious Diseases and Allergology, Jan Kochanowski University, 25-317 Kielce, Poland.
J Clin Med. 2025 Aug 25;14(17):5992. doi: 10.3390/jcm14175992.
: The aim of this analysis of data from the multi-year nationwide SARSTer program in Poland was to compare the clinical presentation and course of COVID-19 in the last two infectious seasons. : Clinical data from 719 consecutive patients hospitalized between April 2023 and March 2024 were compared with data from 360 patients hospitalized between 1 April 2024 and 31 March 2025. : In the 2023/2024 season, hospitalizations due to COVID-19 occurred primarily between September and January, and in the 2024/2025 season, the majority of hospitalizations occurred between July and November. In the 2024/2025 season, we documented a change in the age structure, with an increasing predominance of hospitalized patients over 70 years of age (68% vs. 60% in 2023/2024), a milder disease manifestation, reflected in a significantly lower percentage of patients with pulmonary lesions (19% vs. 24%), an improvement in the clinical course of the disease, reflected in a halving of the number of hospitalizations, a significantly higher percentage of patients with clinical improvement in subsequent weeks of hospitalization, including those discharged from the hospital within the first week (39% vs. 30%), and a significantly lower mortality rate (4.7% vs. 7.9%), especially among patients over 70 years of age (5.4% vs. 10.4%). This indicates that the trend of a milder disease course initiated by the emergence of the Omicron variant continues. : In conclusion, our findings provide real-world clinical evidence of the evolution of the COVID-19 situation in the post-pandemic era.
本次对波兰多年全国性SARS-CoV-2项目数据的分析旨在比较过去两个感染季节中COVID-19的临床表现和病程。将2023年4月至2024年3月期间连续住院的719例患者的临床数据与2024年4月1日至2025年3月31日期间住院的360例患者的数据进行了比较。在2023/2024季节,COVID-19导致的住院主要发生在9月至1月之间,而在2024/2025季节,大多数住院发生在7月至11月之间。在2024/2025季节,我们记录到年龄结构发生了变化,70岁以上住院患者的占比增加(68%对2023/2024年的60%),疾病表现较轻,表现为肺部病变患者的百分比显著降低(19%对24%),疾病临床病程有所改善,表现为住院人数减半,住院后续几周临床改善的患者百分比显著更高,包括第一周内出院的患者(39%对30%),死亡率显著降低(4.7%对7.9%),尤其是70岁以上患者(5.4%对10.4%)。这表明由奥密克戎变异株出现引发的疾病病程较轻的趋势仍在持续。总之,我们的研究结果为大流行后时代COVID-19情况的演变提供了真实世界的临床证据。